Clinical evaluation of ultrasmall superparamagnetic iron oxide particles for liver imaging
- 31 August 1996
- journal article
- research article
- Published by Elsevier in Academic Radiology
- Vol. 3, S409-S412
- https://doi.org/10.1016/s1076-6332(96)80600-3
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).American Journal of Roentgenology, 1995
- Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging.Radiology, 1994
- AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes.Radiology, 1994
- Phase I clinical evaluation of a new iron oxide MR contrast agentJournal of Magnetic Resonance Imaging, 1994
- Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging.Radiology, 1994
- Contrast-enhanced MR imaging of the liver.Radiology, 1992
- Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.Radiology, 1992
- Blood-Pool Contrast Media Are the Ideal Agents for Computed TomographyInvestigative Radiology, 1991
- Advances in contrast-enhanced MR imaging. Principles.American Journal of Roentgenology, 1991
- Liver tumor imaging: current concepts.American Journal of Roentgenology, 1990